Most Asian countries fail to include rotavirus vaccine in national immunization programs citing cost as barrier

"Most countries in Asia have yet to make the rotavirus vaccine part of their national immunization program (NIP), despite a World Health Organization (WHO) recommendation to do so," IRIN reports. "Worldwide, rotavirus accounts for 37 percent of all diarrhea deaths in children under five with 95 percent of those deaths occurring in developing countries," the news service states, noting, "There are no antibiotics or any other drug to fight the infection and since 2009 WHO has recommended the global use of the rotavirus vaccine." Forty-one countries worldwide include rotavirus vaccine in their NIPs, but "only two countries in Asia -- Philippines and Thailand -- are vaccinating (or are about to) children against rotavirus," according to IRIN. An email to IRIN from WHO's Manila office stated, "Price continues to be an important barrier to introducing rotavirus vaccine," the news service notes (9/7).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research suggests no need for yellow fever vaccine booster after initial dose